COVID-19 Update: See the latest on our visitor policy here. Learn More
A Phase 2 Study of Fedratinib in Myelodysplastic /Myeloproliferative Neoplasms (MDS/MPNs) and Chronic Neutrophilic Leukemia (CNL)
The purpose of the study is to evaluate the effectiveness, safety, and tolerability of fedratinib in participants with myelodysplastic/myeloproliferative neoplasms (MDS/MPNs) and chronic neutrophilic leukemia (CNL).
1. To evaluate the efficacy of fedratinib in patients with MDS/MPNs and CNL; 2. To evaluate the safety and tolerability of fedratinib in MDS/MPNs and CNL; 3. To evaluate the effect of fedratinib in MDS/MPNs and CNL on patient-reported outcomes.
Back to top
Please call 1-888-663-3488 for support from a Moffitt representative. New Patients and Healthcare Professionals can submit an online form by selecting the appropriate button below. Existing patients can call 1-888-663-3488. Click here for a current list of insurances accepted at Moffitt.
NEW PATIENTS To request a new patient appointment, please fill out the online form or call 1-888-663-3488.
REFERRING PHYSICIANS Providers and medical staff can refer patients by submitting our online referral form.
Moffit now offers Virtual Visits for patients. If you are eligible for a virtual appointment, our scheduling team will discuss this option further with you.